Welcome to your premier source for the latest in AI, cryptocurrency, blockchain, and AI search tools—driving tomorrow's innovations today.

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...

Elon Musk’s team is leading an effort to link government databases, to the alarm of privacy and security experts. By Emily Badger and Sheera Frenkel The federal government knows your mother’s maiden ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community. Issues are used to track todos, bugs, feature requests, and more.

Exscientia Plc (EXAI) has released an update. Don't Miss our Black Friday Offers: Exscientia Plc merges with Recursion to form a powerful AI-driven drug discovery platform, marking a significant step ...

Abstract: Sorting is a classic algorithm that is fundamental building block of many algorithms. Many algorithms requiring high speed data processing nowadays are hardware accelerated using ...

Utah-based Recursion, a clinical-stage biotech company specialising in drug discovery, has entered into a definitive agreement to merge with Oxford-based Exscientia, a clinical-stage drug design and ...

Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia, said Thursday that they will merge into one company. The new company will continue using the ...